Edition:
India

Innate Pharma SA (IPH.PA)

IPH.PA on Paris Stock Exchange

6.11EUR
14 Jun 2019
Change (% chg)

€-0.09 (-1.37%)
Prev Close
€6.20
Open
€6.16
Day's High
€6.20
Day's Low
€6.04
Volume
71,477
Avg. Vol
190,023
52-wk High
€9.44
52-wk Low
€4.41

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Dec '18 63.01 0.321
Jun '18 16.88 -0.281
FY 2017 Dec '17 17.08 -0.457
Jun '17 15.55 -0.433
 
*Note: Units in Millions ofEuro
**Note: Units in Euro

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-19 1 73.10 73.10 73.10 --
Quarter Ending Dec-19 1 8.20 8.20 8.20 --
Year Ending Dec-19 4 74.47 126.10 35.00 100.28
Year Ending Dec-20 6 81.19 118.10 42.40 79.31
Earnings (per share)
Quarter Ending Jun-19 1 0.42 0.42 0.42 --
Quarter Ending Dec-19 1 -0.59 -0.59 -0.59 --
Year Ending Dec-19 3 -0.50 0.16 -1.48 0.21
Year Ending Dec-20 6 -0.44 0.22 -0.89 -0.22
Sales and Profit Figures in Euro (EUR);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % 213.63 65.14 49.76
EPS (TTM) % 286.85 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Innate Pharma SA

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -5.23 -9.58 96 --
13 Week -2.14 -6.06 99 --
26 Week -6.57 -10.49 99 --
52 Week -8.20 -23.27 99 --
YTD -27.99 -34.68 94 --
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 19.05%
# of Holders: 48
Total Shares Held: 12,202,227
3 Mo. Net Change: -168,090
# New Positions: 0
# Closed Positions: 3
# Increased Positions: 4
# Reduced Positions: 10
# Net Buyers: -6
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.